SCHEMBL13634392

SCHEMBL13634392

CCC1Cc2ccc(Cl)cc2N1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ADRA2A P08913 2/20 0.46
▸ PNMT P11086 2/20 0.46
▸ ADRA2B P18089 2/20 0.46
▸ ADRA2C P18825 2/20 0.46
▸ BRD4 O60885 1/20 0.42
▸ CREBBP Q92793 1/20 0.42
▸ HTR2A P28223 4/20 0.42
▸ HTR2C P28335 4/20 0.42
▸ HTR2B P41595 2/20 0.42
▸ TRPM5 Q9NZQ8 8/20 0.40
▸ TRPM4 Q8TD43 6/20 0.40
▸ CMA1 P23946 1/20 0.40
▸ AHR P35869 1/20 0.40
▸ CRHR1 P34998 1/20 0.38
▸ HTR3E A5X5Y0 1/20 0.37
▸ HTR3B O95264 1/20 0.37
▸ HTR3A P46098 1/20 0.37
▸ HTR3D Q70Z44 1/20 0.37
▸ HTR3C Q8WXA8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15896885 0.80 PNMT (0.47) ADRA2APNMTADRA2BADRA2CBRD4
SCHEMBL550480 0.79 PNMT (0.46) ADRA2APNMTADRA2BADRA2CBRD4
SCHEMBL27528311 0.77 ITGB3 (0.47) TRPM5TRPM4CMA1AHR
SCHEMBL15445210 0.76 PNMT (0.44) ADRA2APNMTADRA2BADRA2CBRD4
SCHEMBL7897325 0.76 CMA1 (0.43) ADRA2AADRA2BADRA2CBRD4CREBBP
SCHEMBL549073 0.76 CREBBP (0.59) ADRA2APNMTADRA2BADRA2CBRD4
SCHEMBL22955423 0.76 CREBBP (0.59) ADRA2APNMTADRA2BADRA2CBRD4
SCHEMBL10841342 0.75 AR (0.43) ADRA2APNMTADRA2BADRA2CHTR2A
SCHEMBL25696612 0.74 MGAM (0.37) ADRA2APNMTADRA2BADRA2CBRD4
SCHEMBL20804518 0.73 AR (0.40) BRD4CREBBPHTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612075-B2 Substituted oxoazaheterocyclyl compounds AVENTIS PHARMACEUTICALS INC. (US) 2009-11-03 — — US disclosed
Send feedback